Currently browsing tag

ludwig-burger

Roche Beats Forecasts on New Drugs and One-Off Gain

By Ludwig Burger BASEL, Switzerland (Reuters) – Switzerland's Roche beat market expectations for adjusted net income in the first six months of the year, helped by cancer drug sales but also inflated by a one-off gain from its pensions scheme. Core earnings per share, adjusted for certain items, rose 7 percent to 7.74 Swiss francs ($7.86), where analysts had expected 7.52 francs on average. Deutsche Bank analyst Tim Race said that excluding that effect, results were broadly in line with expectations.

Germany in push to encourage antibiotics development

By Ludwig Burger FRANKFURT (Reuters) – Germany is looking to encourage the development of more powerful antibiotics against the growing threat of drug-resistant superbugs, the country’s pharmaceutical industry association said on Wednesday. The health ministry in Berlin is to hold talks later this year with Germany’s pharma lobby VFA, which will propose loosely modeling any new rules for antibiotics on the so-called orphan drug status that is awarded to experimental treatments of rare diseases, VFA’s chairman Hagen Pfundner said.